Statistics

Total Visits

Views
Low doses vs. high doses of the angiotensin converting-enzyme inhibitor lisinopril in chronic heart failure: a cost-effectiveness analysis based on the Assessment of Treatment with Lisinopril and Survival (ATLAS) Study(legacy) 113
Low doses vs. high doses of the angiotensin converting-enzyme inhibitor lisinopril in chronic heart failure: a cost-effectiveness analysis based on the Assessment of Treatment with Lisinopril and Survival (ATLAS) Study(legacy) 49

Total Visits per Month

October 2023 November 2023 December 2023 January 2024 February 2024 March 2024 April 2024
Low doses vs. high doses of the angiotensin converting-enzyme inhibitor lisinopril in chronic heart failure: a cost-effectiveness analysis based on the Assessment of Treatment with Lisinopril and Survival (ATLAS) Study 1 6 2 0 0 3 0

File Downloads

Views

Top Country Views

Views
United States 68
Australia 15
China 11
Netherlands 8
Vietnam 5
France 4
Finland 1
Philippines 1

Top City Views

Views
Ashburn 37
Kaleen 15
Fairfield 12
Rotterdam 8
Hanoi 5
Cambridge 3
Seattle 2
Atlanta 1
Boardman 1
Chengdu 1